Project: AMR Dx Global

Acronym AMR Dx Global (Reference Number: JPIAMR_2018_N021)
Duration 01/01/2019 - 31/10/2020
Project Topic AMR Dx Global is a transnational, multi-sectorial, multi-stakeholder and interdisciplinary network focussed on rapid diagnostics training and capacity building to tackle the global threat of antimicrobial resistance with a One Health approach. The network is coordinated by the University of Edinburg and brings together partners from 18 countries including international organisations like WHO, FIND, AMREF and ICAN. AMR Dx Global will develop a Strategic Action Plan on training to support the formation of the JPIAMR-VRI and focus on Diagnostics as one of the six priority topics of the JPIAMR Strategic Research Agenda. AMR Dx Global evolved from the successful JPIAMR Working Group AMR-RDT, which identified barriers to development, implementation and use of rapid diagnostics to tackle AMR. The findings of AMR-RDT has been published in Nature Reviews Microbiology and Lancet Infectious Diseases for publication. As before, AMR Dx Global has assembled an outstanding group of experts selected to match the scope of the JPIAMR VRI. The new network provides exceptional access to and input from the leading national and international institutions, networks and activities in the field, which amplifies its immediate reach. Most importantly, the extensive coverage of existing global, international and national initiatives relevant to AMR, diagnostics, training, teaching and capacity building constitutes an exceptional opportunity for JPIAMR-VRI to receive input to its strategy and mitigate the risk of duplication amongst the many emerging transnational initiatives on AMR. AMR Dx Global will run a twelve-month programme including two major meetings and structured data collection on existing strategies, needs and gaps in AMR diagnostics training and capacity building to develop the Strategic Action Plan on training for Diagnostics. The framework for AMR Dx Global and its ultimate vision is the set-up of a JPIAMR Virtual School of Diagnostics as part of the JPIAMR-VRI. Such Virtual School would create world-leading opportunity to connect the global AMR diagnostics community and stakeholders with the next generation of AMR scientists and turn the challenge of AMR into an opportunity for the next generation of researchers and the sustainable development goals.
Website visit project website
Network JPI AMR
Call 8th Joint Call of JPIAMR

Project partner

Number Name Role Country
1 University of Edinburgh Coordinator United Kingdom
2 BioMérieux Observer France
3 University of the Arts London Observer United Kingdom
4 KTH Royal Institute of Technology Observer Sweden
5 Cairo University Observer Egypt
6 Foundation for Innovative New Diagnostics Observer Switzerland
7 Longitude Prize, Nesta Observer United Kingdom
8 University of Tübingen Observer Germany
9 World Health Organization (WHO) Observer Switzerland
10 Fraunhofer Institute for Cell Therapy and Immunology Observer Germany
11 Curetis GmbH Observer Germany
12 Robert Koch Institute Observer Germany
13 University Hospital of North Norway and Arctic University of Norway Observer Norway
14 Lahey Hospital & Medical Center and Harvard Medical School Observer United States
15 Fraunhofer Institute for Cell Therapy and Immunology Observer Germany
16 University of Antwerp Observer Belgium
17 Ben-Gurion University Observer Israel
18 Amref International University Observer Kenya
19 National Autonomous University of Mexico Observer Mexico
20 Ahimsa Fund Observer France
21 Erasmus MC University Medical Center Observer Netherlands
22 Barcelona Institute for Global Health (ISGlobal) Observer Spain
23 University Hospital Münster Observer Germany
24 Hahn-Schickard, University of Freiburg Observer Germany
25 National Infection Service, Public Health England Observer United Kingdom
26 Ain Shams University Observer Egypt
27 ND4ID (New Diagnostics for Infectious Diseases) Observer Belgium
28 Center for Disease Dynamics, Economics & Policy Observer India
29 Indian Institute of Technology Observer India
30 London School of Hygiene & Tropical Medicine Observer United Kingdom
31 London School of Hygiene & Tropical Medicine Observer United Kingdom
32 University of Edinburgh Observer United Kingdom
33 Infection Control Africa Network Observer South Africa
34 Max von Pettenkofer Institute Munich Observer Germany
35 Freie Universität Berlin Observer Germany
36 University Hospitals Geneva Observer Switzerland
37 University of Toronto Observer Canada
38 Centre for Cellular and Molecular Platforms Observer India
39 University of Edinburgh Observer United Kingdom
40 Institute of Medical Microbiology and Infection Control Observer Germany
41 European Public Health Association and Gvm Care and Research Observer Italy
42 MSF Observer Switzerland